Ten years of ‘ecstasy’

Shulgin A. , Shulgin A. PIHKAL. A Chemical Love Story. Berkeley CA: Transform Press, 1991.

Saunders N. Ecstasy Reconsidered. London: Nicholas Saunders, 1997.

Collin M. Altered State. The Story of Ecstasy Culture and Acid House. London: Serpent's Tail, 1997.

Perouka S.J. Incidence of recreational use of 3,4 methylenedimethoxymethamphetamine (MDMA, “Ecstasy”) on an undergraduate campus. N Engl J Med 1987; 317: 1542–3.

Parliamentary Office of Science and Technology. Common Illegal Drugs and their Effects—Cannabis, Ecstasy, Amphetamines and LSD. London: POST, 1996.

Green A.R. , Cross A.J. , Goodwin G.M. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”). Psychopharmacology 1996; 119: 247–60.

Greer G. , Tolbert A. Subjective reports of the effects of 3,4-methylenedioxmethamphetamine in a clinical setting. J Psychoactive Drugs 1991; 38: 339–44.

Solowij N. , Hall W. , Lee N. Recreational MDMA use in Sydney: a profile of ‘ecstasy' users and their experiences with the drug. Br J Addict 1992; 87: 1161–72.

McCann U.D. , Slate S.O. , Ricaurte G.A. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’). Drug Safety 1996; 15: 107–15.

Curran H.V. , Travill R.A. Mood and cognitive effects of ± 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week-end ‘high' followed by mid-week low. Addiction 1997; 92: 821–31.

Milroy C.M. , Clark J.C. , Forrest A.R.W. The pathology of deaths associated with ‘Ecstasy' and ‘Eve' misuse. J Clin Pathol 1996; 49: 149–53.

Dowling G.P. , McDonough E. , Bost R. ‘Eve' and ‘ecstasy’. A report of five deaths associated with the use of MDEA and MDMA. JAMA 1987; 257: 1615–17.

Chadwick I.S. , Curry P.D. , Linsley A. , Freemont A.J. , Doran B. Ecstasy, 3,4-methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med 1991; 84: 371.

Campkin N.T. , Davies U.M. Another death from ‘ecstasy’. J R Soc Med 1992; 85: 61.

Henry J.A. , Jeffreys K.J. , Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (‘ecstasy’). Lancet 1992; 340: 384–7.

Forrest A.R. , Galloway J.D. , Marsh G.A. , Strachan J.C. , Clark A. A fatal overdose with 3,4-methylenedioxymethamphetamine derivatives. Forensic Sci Int 1994; 64: 57–9.

Coore J.R. A fatal trip with ecstasy: a case of 3,4-methylenemethdioxyamphetamine/3,4-methylenedioxyamphetamine. J R Soc Med 1996; 89: 51–2.

Fineschi V. , Masti A. Fatal poisoning by MDMA (ecstasy) and MDEA: a case report. Int J Leg Med 1996; 108: 272–5.

Lora-Tamayo C. , Tena T. , Rodriguez A. Amphetamine derivative related deaths. Forensic Sci Int 1997; 85: 149–57.

Wienman W. , Bohnert M. Lethal monointoxication by overdosage of MDEA. Forensic Sci Int 1998; 91: 91–101.

Fahal I.B. , Sallomi D.F. , Yaqoob M. , Bell G.M. Acute renal failure after ecstasy. BMJ 1992; 305: 29.

Harries D.P. , de Silva R.N. Ecstasy and intracerebral haemorrhage. Scott Med J 1992; 37: 150–2.

Rothwell P.M. , Grant R. Cerebral venous sinus thrombosis induced by ecstasy. J Neurol Neurosurg Psychiatry 1993; 56: 1035.

Gledhill J.A. , Moore D.F. , Bell D. , Henry J.A. Subarachnoid haemorrhage associated with MDMA abuse. J Neurol Neurosurg Psychiatry 1993; 56: 1036–7.

Hughes J.C. , McCabe M. , Evans R.J. Intracranial haemorrhage associated with ingestion of “Ecstasy”. Arch Emerg Surg 1993; 10: 372–4.

Levine A.J. , Drew S. , Rees G.M. ‘Ecstasy' induced pneumomediastinum. J R Soc Med 1993; 83: 233–4.

Marsh J.C. , Abboudi Z.H. , Gibson F.M. , Scopes J. , Daly S. , O'Shaunnessy D.F. Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine (‘ecstasy’). Br J Haematol 1994; 88: 281–85.

Maxwell D.L. , Polkey M.I. , Henry J.A. Hyponatraemia and catatonic stupor after taking “ecstasy”. BMJ 1993; 307: 1399.

Holden R. , Jackson M.A. Near-fatal hyponatraemic coma due to vasopressin over-secretion after “ecstasy” (3,4-MDMA). Lancet 1996; 347: 1052.

Henry J.A. , Fallon J.K. , Kicman A.T. , Hutt A.J. , Cowan D.A. , Forsling M. Low-dose MDMA (“ecstasy”) induces vasopressin secretion. Lancet 1998; 351: 1784.

Parr M.J.A. , Low H.M. , Botterill P. Hyponatraemia and death after ‘ecstasy' ingestion. Med J Aust 1997; 166: 143–6.

Shearman J.D. , Satsangi J. , Chapman R.W.G. , Ryley N.G. Misuse of ecstasy. BMJ 1992; 305: 309.

Gorard D.A. , Davies S.A. , Clark M.L. Misuse of ecstasy. BMJ 1992; 305: 309.

deMan R.A. , Wilson J.H. , Tjen H.S. Acute liver failure caused by methylenedioxymethamphetamine ‘ecstasy’. Ned Tijdschr Geneesk 1993; 137: 727–9.

Dykhuizen R.S. , Brunt P.W. , Atkinson P. , Simpson J.G. , Smith C.C. Ecstasy induced hepatitis mimicking viral hepatitis. Gut 1995; 36: 939–41.

Ellis A.J. , Wendon J.A. , Portmann B. , Williams R. Acute liver damage and ecstasy ingestion. Gut 1996; 38: 454–8.

Jansen K. Adverse psychological effects associated with use of ecstasy (MDMA) and their treatment. In: Saunders N. , ed. Ecstasy Reconsidered. London: Nicholas Saunders, 1997.

McCann U.D. , Ridenour A. , Shaham Y. , Ricaurte G.A. Brain serotonergic neurotoxicity after MDMA (‘ecstasy’): a controlled study in humans. Neuropsychopharmacology 1994; 10: 129–38.

Ricaurte G.A. , Forno L.S. , Wilson M.A. , DeLanney L.E. , Irwin I. , Molliver M.E. (±)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA 1988; 260: 51–5.

McCann U.D. , Szabo Z. , Scheffel U. , Dannais R.F. , Ricaurte G.A. Positron emission tomographic evidence of toxic effect of MDMA (‘Ecstasy’) on transerotonin neurons in human beings. Lancet 1998; 352: 1433–7.

Byard R.W. , Gilbert J. , James R. , Lokan R.J. Amphetamine derivative deaths in South Australia—Is “Ecstasy“ the culprit? Am J Forens Med Pathol 1998; 19: 261–5.